Table 7.
Outcomes.
| Toxoplasmosis/tuberculoma | Brain abscess | Toxoplasmosis | Tuberculomas | n | |
|---|---|---|---|---|---|
| Discharged home | 72 | 13 | 3 | 3 | 91 |
| Sent to base hospital/step down facility | 8 | 1 | 0 | 0 | 9 |
| Deaths in the wards | 9 | 0 | 0 | 0 | 9 |
| Transferred to neurosurgery | 0 | 1 | 0 | 0 | 1 |
TB: tuberculosis.
Outcome of groups that received early therapy of co-trimoxazole (65%) compared to the group that had delayed or no co-trimoxazole (0%) yielded fewer deaths with p-value of 0.0002 (Pearson’s χ2).
Similar findings were documented for the group that received early therapy of anti-TB drugs (79%) compared to the group with delayed or no anti-TB drugs (0%) with p-value of <0.0001 (Pearson’s χ2).